Our series of indexes serve as benchmarks for mutual funds and ETFs. Explore CRSP Indexes. CRSP indexes has transformed the finance market. See what we can do for your organization.
The Investor Relations website contains information about CRISPR Therapeutics's business for stockholders, potential investors, and financial analysts.
Investors. Playing in picture-in-picture. undefined ... CRISPR Therapeutics Corporate Presentation. View our corporate presentation to learn more about our ...
People also ask
What will CRSP stock be worth in 2025?
What is the future value of CRSP?
Is CRISPR Therapeutics a buy or sell?
Who is the largest shareholder of CRISPR?
Stock Quote & Chart · Historical Price · Investment Calculator. Shareholder Services. Investor FAQs · Document Request · Contact IR · Back to CRISPR ». Past ...
CRISPR Therapeutics AG Common Shares (CRSP) Earnings Report Date
www.nasdaq.com › ... › Stocks › CRSP
According to Zacks Investment Research, based on 11 analysts' forecasts, the consensus EPS forecast for the quarter is $-1.63. The reported EPS for the same ...
Investor FAQs · Document Request · Contact IR · Back to CRISPR ». Email Alerts ... Contact IR. Interested in joining our team? Careers at CRISPR. © 2024 CRISPR ...
Find the latest CRISPR Therapeutics AG Common Shares (CRSP) annual income statements, balance sheets, financial statements, ratios, and cash flow data at ...
Rating
(722,260)
Crispr Therapeutics AG (CRSP) stock investors activity – investors allocate an average of 4.33% to CRSP, based on 722260 active investor portfolios.